Affiliation:
1. Sanjay Gandhi Post Graduate Institute of Medical Sciences
2. Sanjay Gandhi Postgraduate Institute of Medical Sciences
Abstract
Abstract
Next Generation Sequencing (NGS) technology is being widely used for preconception carrier screening of couples with or without family history of a genetic disorder, newborn screening, and for personalized and preventive treatments although its knowledge is still limited in general population and health care workers. In this pilot study, we have assessed the knowledge, attitude and concerns related to next generation sequencing in the general population in India. The present prospective cross-sectional survey was performed between June 2022 and September 2022. The predesigned semi structures questionnaire was used to collect the data. A total of 103 apparently healthy individuals completed the questionnaires related to basic understanding assessment, personal utility, information sharing with family members, concerns surrounding NGS and positive impact. The participants in this study demonstrated relatively good general understanding of the information sheet (78% average correct response). We also observed that the majority wished to know the results of secondary findings for treatable conditions, untreatable conditions and also variants of uncertain significance. The public also wanted to sequence all the genes in their body, given a chance, and based on the results- carrier status, drug response, or susceptibility to various conditions, plan of action would be decided. They had a general willingness to share the results with their relatives. About half of them also wished to undergo prenatal testing based on the VUS result.
Publisher
Research Square Platform LLC
Reference24 articles.
1. Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study;Hart MR;Genetics in Medicine,2019
2. Manickam K, McClain MR, Demmer LA, Biswas S, Kearney HM, Malinowski J, et al. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine. 2021 Nov;23(11):2029–37.
3. “Not Tied Up Neatly with a Bow”: Professionals’ Challenging Cases in Informed Consent for Genomic Sequencing;Tomlinson AN;J Genet Counsel.,2016
4. Parents’ experiences of receiving their child’s genetic diagnosis: A qualitative study to inform clinical genetics practice;Ashtiani S;Am J Med Genet,2014
5. ‘Diagnostic shock’: the impact of results from ultrarapid genomic sequencing of critically unwell children on aspects of family functioning;Bowman-Smart H;Eur J Hum Genet,2022